Concept, design, and preclinical evaluation of quinolonyl lactam antibacterials

Advances in Experimental Medicine and Biology

Volumn 456, Issue , 1998, Pages 239-267

  Hershberger, P M ^a   Demuth T P , Jr ^a  

^a PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CARBACEPHEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; LACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; DRUG DESIGN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0032226555     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-4897-3_13     Document Type: Review

References (85)

1. Cephalosporin 3′-quinolone esters with a dual mode of action
2. Dual-action cephalosporins incorporating a 3′-tertiary-amine-linked quinolone
3. Dual-action cephalosporins:cephalosporin3′-quaternaryammoniumquinolones
4. Dual-action cephalosporin 3′-quinolone carbamates
5. Mechanism-based dual-action cephalosporins
6. A N-nitrosochloroethyl-cephalosporin carbamate prodrug for antibody-directed enzyme prodrug therapy (ADEPT)
7. Cephalosporin nitrogen mustard carbamate prodrugs for ADEPT
8. 2-(Heteroatom-substituted)methyl penems. I. Sulphur derivatives
9. In vitro and in vivo activity of carbamate-linked dual-action antibacterial Ro 24-4383
10. In vivo evaluation of a dual-action antibacterial, Ro 23-9424, compared to cefotaxime and fleroxacin
11. In vivo efficacy and pharmacodynamics of four quinolonyl-lactam antibacterial agents in mice
12. Reactions of TMS1 with cephalosporin esters
13. Fluoronaphthyridines and quinolones as antibacterial agents. 2. Synthesis and structure-activity relationships of new 1-tert-butyl 7-substituted derivatives
14. Electronic structures of cephalosporins and penicillins. 4. Modeling acylation by the β-lactam ring
15. Electronic structures of cephalosporins and penicillins. 9. Departure of a leaving group in cephalosporins
16. Resistance to antibiotics
17. Pharmacokinetic and mechanistic differences between ester- and carbamate-linked dual-action cephalosporins
18. Pharmacokinetics of Ro 23-9424, a dual-action cephalosporin, in animals
19. Cephalosporin acids. Part II. Displacement of the acetoxy group by nucleophiles
20. Palladium-catalyzed chemistry of β-lactam vinyl triflates: Coupling with organostannanes and alkoxycarbonylation
21. Dual-action penems and carbapenems
22. Dual-action β-lactam antibacterials
23. Synthesis and mechanistic studies of a 'tetrazole-tethered' cephalosporin-quinolone hybrid
24. Preclinical evaluation of quinolonyl-lactam antibacterials: Compounds designed to combat drug-resistance in bacteria
25. C-10 Quinolonyl-cephem carbamates: Synthesis, and evaluation of a new class of antibacterial agents
26. Preparation and antimicrobial activity of novel C-10 quinolonyl-cephem dithiocarbamates
27. Synthesis and antibacterial activity of new C-10 quinolonyl-cephem esters
28. Quinolone antibacterial containing the new 7-[3-(1-aminoethyl)-1-pyrrolidinyl] side chain: The effects of the 1-aminoethyl moiety and its stereochemical configurations on potency and in vivo efficacy
29. Structure-activity studies of quinolone-penems in genetically defined strains of Escherichia coli
30. Elimination of a good leaving group from the 3′-position of a cephalosporin need not be concerted with β-lactam ring opening: TEM-2 β-lactamase-catalyzed hydrolysis of pyridine-2-azo-4′-(N′,N′-dimethylaniline) cephalosporin (PADAC) and of cephaloridine
31. Dual-action penems
32. Mechanisms of action of cephalosporin 3′-quinolone esters, carbamates, and tertiary amines in Escherichia coli
33. Mode of action of the dual-action cephalosporin Ro 23-9424
34. Antibacterial activity of multifunctional quinolonyl-cephem 2°-amines
35. In vitro activity of Ro 23-9424, a dual-action cephalosporin, compared with activities of other antibiotics
36. Products of aminolysis and enzymic hydrolysis of the cephalosporins
37. Changes in proton-magnetic-resonance spectra during aminolysis and enzymic hydrolysis of cephalosporins
38. Design and synthesis of a cephalosporin-carboplatinum prodrug activatable by a β-lactamase
39. Synthesis and biological evaluation of 2-thioether-linked quinolonyl carbapenems
40. Multifunctional quinolonyl-penem carbamates and their antibacterial activities
41. Cephalosporin 3′-phloroglucide esters and 7-(phloroglucamido)cephalosporins as novel antibacterial agents
42. Activity of new penems against defined MRSA strains
43. Antimicrobial activity of Ro 23-9424, a novel ester-linked co-drug of fleroxacin and desacetylcefotaxime
44. Preparation of iodoallylic alcohols via hydrostannylation: Spectroscopic proof of structures
45. Mechanism-based dual-action cephalosporins
46. Structure-activity relationships for quinolonyl-lactam antibacterial binding to Staphylococcus aureus penicillin-binding proteins
47. In vitro activity of quinolonyl-cephem amines
48. Synthesis and antibacterial activity of cephalosporin 3′-quinolone dithiocarbamate
49. Physicochemical properties, stabilities, and pharmacokinetics of cephalosporin 3′-quinolone dithiocarbamate
50. The challenge of antibiotic resistance
51. Synthesis and multifunctional antibacterial activity of new quinolonyl-cephem 3°-amines
52. Synthesis and multifunctional antibacterial activity of amine-linked quinolonyl penems
53. Prediction of the pharmacokinetics and dosing schedule of quinolonyl-lactam (QL) antibacterials in humans from data obtained in animals
54. Comparison of the pharmacokinetics of penem versus cephem quinolonyl-lactam (QL) antibacterials in three mammalian species
55. Preparation and characterization of a β-lactamase-Fab' conjugate for the site-specific activation of oncolytic agents
56. Synthesis and structure-activity relationships of 5-substituted 6,8-difluoroquinolones, including sparfloxacin, a new quinolone antibacterial agent with improved potency
57. 10-esters of desacetylcephalothin
58. 10-dipeptidyl cephalosporin esters
59. 3 isomerization of the cephalosporin
60. 10-ester of an antibiotic dipeptide
61. Studies on condensed-heterocyclic azolium cephalosporins
62. A new cephalosporin with a dual mode of action
63. Escherichia coli resistant to cephalosporins and quinolones is still susceptible to the cephalosporin-quinolone ester Ro 23-9424
64. The mechanisms of reactions of β-lactam antibiotics
65. Mechanism of β-lactam ring opening in cephalosporins
66. In vitro activity of Ro 23-9424, a dual action antibacterial agent, against bacterial isolates from cancer patients compared with those of other agents
67. Asymmetric synthesis and properties of the enantiomers of the antibacterial agent 7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-1,4-dihydro-6-fluoro-4- oxo-1,8-naphthyridine-3-carboxylic acid hydrochloride
68. In vitro activity of two new quinolonyl-penem carbamates
69. Evaluation of new quinolonyl penem carbamates
70. Aspects of the mechanism of action of some cephalosporins
71. Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids
72. Synthetic carbapenem antibiotics I. 1-β-methylcarbapenem
73. Discovery and development of new antibiotics: The problem of antibiotic resistance
74. Ro 23-9424
75. Asymmetric total synthesis of an important 3-(hydroxymethyl)carbacephalosporin
76. A novel carbapenem antibiotic, SM-7338 structure-activity relationships
77. Monoclonal antibody-β-lactamase conjugates for the activation of a cephalosporin mustard prodrug
78. Synthesis and evaluation of dual action cephalosporins as elastase inhibitors
79. Preparation and comparative antibacterial activity of quinolonyl-cephem amines and carbamates
80. Synthesis and biological evaluation of quinolonyl-carbacephalosporin antibacterials
81. Studies on β-lactam antibiotics